Functioning pancreatic neuroendocrine neoplasms: Diagnosis and current treatment

Abstract Pancreatic functioning neuroendocrine neoplasms (PanNENs) are rare and characterized by variable and heterogeneous clinical manifestations, comprising both symptoms and signs of tumor growth and systemic manifestations of hormonal hypersecretion. The diagnosis is challenging due to their rarity, neoplasm localization and diverse secretory profile. A subset of these neoplasms may develop in the context of inherited syndromes and harbor specific genetic alterations requiring genetic counseling of other family members. These particular features make the management of patients with a functioning PanNEN syndrome requiring a multidisciplinary approach. Surgical resection of local disease, antisecretory medical treatment, locoregional treatment and systemic treatments are employed on an individualized basis. The treatment landscape of advanced NENs progressing after systemic treatment or after exhibiting intolerance to sequential lines of treatment is rapidly evolving supporting the introduction of additional therapies with promising results.

Authors

Institutions

Publication Details

Journal
Endocrine Oncology
Published
2026-09-25
DOI
https://doi.org/10.1530/eo-26-0005
Primary Topic
Neuroendocrine Tumor Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Functioning pancreatic neuroendocrine neoplasms: Diagnosis and current treatment

Ariadni Spyroglou, Gregory Kaltsas, Anna G. Angelousi, Krystallenia Alexandraki et al.
Endocrine Oncology
Neuroendocrine Tumor Research Advances
article

Functioning pancreatic neuroendocrine neoplasms: Diagnosis and current treatment

Ariadni Spyroglou, Gregory Kaltsas, Anna G. Angelousi, Krystallenia Alexandraki, Marina Tsoli, Panagiota Konstantakou
article en

Abstract

Abstract Pancreatic functioning neuroendocrine neoplasms (PanNENs) are rare and characterized by variable and heterogeneous clinical manifestations, comprising both symptoms and signs of tumor growth and systemic manifestations of hormonal hypersecretion. The diagnosis is challenging due to their rarity, neoplasm localization and diverse secretory profile. A subset of these neoplasms may develop in the context of inherited syndromes and harbor specific genetic alterations requiring genetic counseling of other family members. These particular features make the management of patients with a functioning PanNEN syndrome requiring a multidisciplinary approach. Surgical resection of local disease, antisecretory medical treatment, locoregional treatment and systemic treatments are employed on an individualized basis. The treatment landscape of advanced NENs progressing after systemic treatment or after exhibiting intolerance to sequential lines of treatment is rapidly evolving supporting the introduction of additional therapies with promising results.

Endocrine Oncology
National and Kapodistrian University of Athens (GR), European Neuroendocrine Tumor Society (DE)
Good health and well-being
Openalex Percentile: Top 11%
Neuroendocrine Tumor Research Advances
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Functioning pancreatic neuroendocrine neoplasms: Diagnosis and current treatment — Ariadni Spyroglou, Gregory Kaltsas, et al. · Endocrine Oncology (2026) | TGRS Research Map | TGRS